A transformative study has provided a profound understanding of glioblastoma’s molecular subtypes, revealing the nuances of cellular heterogeneity...
Vous n'êtes pas connecté
The Australian & New Zealand Children’s Haematology/Oncology Group (ANZCHOG)-sponsored OPTIMISE trial has opened to recruitment today at Sydney Children’s Hospital (SCH) and Queensland Children’s Hospital (QCH), marking a promising advancement in children’s cancer therapies utilising precision medicine. As a platform trial, OPTIMISE will be able to test the effectiveness of multiple different treatment options for [...]
A transformative study has provided a profound understanding of glioblastoma’s molecular subtypes, revealing the nuances of cellular heterogeneity...
Scientists from St. Jude Children’s Research Hospital, Seattle Children’s and the Children’s Oncology Group (COG), USA, have identified novel...
Hamad Medical Corporation, Qatar’s leading provider of secondary and tertiary healthcare, is excited to unveil a revolutionary advancement in...
IMAGE:Audrey/stock.adobe.comThe Queensland Government has released the Queensland Level Crossing Safety Strategy, outlining a 10-year strategy aimed...
The installation of an advanced SGRT system represents a major advancement in cancer care for the Cape region.
In a pioneering venture, researchers have harnessed AI and multi-omics to shed light on the intricate pathways of gastric inflammation-induced...
TUESDAY, Aug. 12, 2024 -- An experimental drug based on ancient Chinese herbal medicine can help ease the toxic side effects of chemotherapy and...
In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a formidable strategy in the battle against cancer. These...
A new Cleveland Clinic (USA) study has identified diet-derived molecules called metabolites as main drivers of young-onset colorectal cancer risk,...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced that the U.S. Food and Drug Administration (FDA) has granted...